Annual Shareholders Equity
$168.87 M
+$95.21 M+129.27%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual stockholders equity is $168.87 million, with the most recent change of +$95.21 million (+129.27%) on December 31, 2023.
- During the last 3 years, DNTH annual shareholders equity has risen by +$186.12 million (+1079.01%).
- DNTH annual shareholders equity is now at all-time high.
Performance
DNTH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$337.90 M
-$20.32 M-5.67%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly stockholders equity is $337.90 million, with the most recent change of -$20.32 million (-5.67%) on September 30, 2024.
- Over the past year, DNTH quarterly shareholders equity has increased by +$159.52 million (+89.42%).
- DNTH quarterly shareholders equity is now -9.33% below its all-time high of $372.69 million, reached on March 31, 2024.
Performance
DNTH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DNTH Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +129.3% | +89.4% |
| 3 y3 years | +1079.0% | +89.4% |
| 5 y5 years | +1079.0% | +89.4% |
DNTH Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1079.0% | -9.3% | +358.8% |
| 5 y | 5-year | at high | +1079.0% | -9.3% | +358.8% |
| alltime | all time | at high | +1079.0% | -9.3% | +358.8% |
Dianthus Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $337.90 M(-5.7%) |
| Jun 2024 | - | $358.22 M(-3.9%) |
| Mar 2024 | - | $372.69 M(+120.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $168.87 M(+129.3%) | $168.87 M(-5.3%) |
| Sep 2023 | - | $178.38 M(+142.2%) |
| Dec 2022 | $73.66 M(-527.0%) | $73.66 M |
| Dec 2021 | -$17.25 M | - |
FAQ
- What is Dianthus Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual shareholders equity year-on-year change?
- What is Dianthus Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly shareholders equity year-on-year change?
What is Dianthus Therapeutics annual stockholders equity?
The current annual shareholders equity of DNTH is $168.87 M
What is the all time high annual shareholders equity for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual stockholders equity is $168.87 M
What is Dianthus Therapeutics annual shareholders equity year-on-year change?
Over the past year, DNTH annual stockholders equity has changed by +$95.21 M (+129.27%)
What is Dianthus Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DNTH is $337.90 M
What is the all time high quarterly shareholders equity for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly stockholders equity is $372.69 M
What is Dianthus Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DNTH quarterly stockholders equity has changed by +$159.52 M (+89.42%)